The European Union's executive is on Tuesday expected to authorize a deal with German biotech firm CureVac to secure up to 405 million doses of its potential COVID-19 vaccine, news agencies have ...

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

German vaccine maker BioNTech SE (NASDAQ:BNTX) revealed on May 20 that it intends to boost its presence in the UK with an ...

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

As well as the economic and employment benefits, BioNTech’s UK investment is expected to deliver tangible improvements in healthcare. The company’s work in personalised cancer immunotherapies, already ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

"BioNTech to invest up to $1.34bn in UK R&D" was originally created and published by Pharmaceutical Technology, a GlobalData ...

The new framework unveiled May 20 says new COVID-19 shots should go only to those ages 65 and up or with underlying medical conditions.

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

Shares of Vaccine stocks are moving higher on Tuesday after documents from the U.S. Food and Drug Administration revealed ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...